SUNESIS PHARMACEUTICALS

Home » SUNESIS PHARMACEUTICALS

Secondary

SUNESIS PHARMACEUTICALS

Pharmaceutical

Sunesis is a biopharmaceutical company focused on the development of novel targeted inhibitors for the treatment of hematologic and solid cancers.

Symbol

SNSS

Last Closing Price
$0.84

Shares
25,000,000

Anticipated Date
July 11, 2019

Underwriters
WELLS FARGO SECURITIES, LLC

This offering is no longer available

To view the prospectus for SUNESIS PHARMACEUTICALS , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253